The Pharmacogenetics of Rituximab: Potential Implications for Anti-CD20 Therapies in Multiple Sclerosis
Michael Zhong, Anneke van der Walt, Maria Pia Campagna, Jim Stankovich, Helmut Butzkueven, Vilija Jokubaitis
Topics & Concepts
PharmacogeneticsRituximabMedicineOcrelizumabMultiple sclerosisAdverse effectOncologyImmunologyInternal medicineGenotypeLymphomaBiologyGeneticsGeneMonoclonal and Polyclonal Antibodies ResearchT-cell and B-cell ImmunologyImmunotherapy and Immune Responses